AtriCure Profile

35.20
USD 0.25  0.71%
84%
23%

Acquisition by Michael Hooven of 10000 shares of AtriCure subject to Rule 16b-3

AtriCure insider trading alert for grant of stock option (right to buy) by Michael Hooven, the corporate stakeholder, on September 16, 2018. This event was filed by Atricure Inc with SEC on 2014-05-15. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

AtriCure Summary

AtriCure (ATRC) is traded on BATS Exchange in USA. It is located in OHIO U.S.A and employs 570 people. AtriCure is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 1.21 B. AtriCure conducts business under Healthcare sector and is part of Medical Instruments & Supplies industry. This company has 35.36 M outstanding shares of which 2.06 M shares are presently shorted by private and institutional investors with about 12.88 trading days to cover. ATRICURE currently holds about 37.07 M in cash with (8.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.05.
Check AtriCure Probability Of Bankruptcy

Ownership Allocation (%)

AtriCure Target Price Odds Analysis

Odds Below 35.2HorizonTargetOdds Above 35.2
88.16%30 days 35.20 11.57%
Based on normal probability distribution, the odds of AtriCure to move above current price in 30 days from now is about 11.57% (This AtriCure probability density function shows the probability of AtriCure Stock to fall within a particular range of prices over 30 days) .

AtriCure Top Holders

AtriCure Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Fmr LlcCommon Shares5.3 M142.2 M
Wellington Management Group LlpCommon Shares3.3 M88.2 M
View AtriCure Diagnostics

AtriCure Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

AtriCure Key Fundamentals

AtriCure Against Markets

AtriCure Current Ratings

AtriCure 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
5 
Chance of
Financial Distress (0 to 100%)
2 
Equity ratings for AtriCure are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company was founded in 2000 and is headquartered in Mason, Ohio. AtriCure operates under Medical Instruments Supplies classification in USA and traded on BATS Exchange. It employs 570 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
AtriCure SEC Filings
AtriCure SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAtriCure
CEO and President and DirectorMichael CarrelView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Instruments & Supplies
InstrumentUSA Stock View All
RegionNorth America
LocationOHIO U.S.A
Business Address7555 Innovation Way
ExchangeBATS Exchange
CIK Number0001323885
CUSIP04963C209
SectorHealthcare
IndustryMedical Instruments & Supplies
BenchmarkDOW
Websitewww.atricure.com
Phone513 755 4100
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 15, 2018

AtriCure Directors

AtriCure Corporate Directors

Michael Hooven Founder and Director
Karen Robards Independent Director
Regina Groves Independent Director
Check also Trending Equities. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.
Search macroaxis.com